Login / Signup

Prognostic impact of PRDM16 expression in acute myeloid leukemia with normal cytogenetics.

Xin XiangQiongyu LuXiaoyu XuPing CaiSuning ChenJin-Lan PanZhao Zeng
Published in: Hematology (Amsterdam, Netherlands) (2022)
PRDM16 is significantly associated with FLT3-ITD and DNMT3A mutation and WT1 expression and serves as a potential prognostic biomarker in CN-AML.
Keyphrases
  • acute myeloid leukemia
  • poor prognosis
  • dna methylation
  • binding protein
  • lymph node metastasis
  • long non coding rna
  • gene expression
  • risk assessment
  • squamous cell carcinoma
  • human health
  • acute lymphoblastic leukemia